XML 25 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value (Tables)
9 Months Ended
Sep. 30, 2012
Fair Value [Abstract]  
Fair value of assets and liabilities measured on a recurring basis
The following tables summarize the valuation of our financial instruments by pricing observability levels as of September 30, 2012 and December 31, 2011:

   
September 30, 2012
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
   
(in thousands)
                                 
Money markets
 
$
311,174
 
 
$
 
 
$
   
$
311,174
 
U.S. Treasury bills
   
     
942,338
     
     
942,338
 
U.K. Treasury bills
   
     
124
     
     
124
 
Equity securities
                               
Growth
   
114,538
     
     
     
114,538
 
Value
   
42,672
     
91
     
     
42,763
 
Blend
   
65,238
     
     
     
65,238
 
Other(1)
   
23,765
     
11
     
     
23,776
 
Fixed Income securities
 
 
 
 
 
 
 
 
 
 
           
Taxable(2)
   
177,744
     
519
     
     
178,263
 
Tax-exempt(3)
   
5,602
     
783
     
     
6,385
 
Derivatives
   
2,097
     
3,349
     
     
5,446
 
Long exchange-traded options
   
9,508
     
     
     
9,508
 
Private equity
 
 
10,699
 
 
 
 
 
 
61,662
     
72,361
 
Total assets measured at fair value
 
$
763,037
   
$
947,215
   
$
61,662
   
$
1,771,914
 
                                 
Securities sold not yet purchased
                               
Short equities – corporate
 
$
18,830
   
$
   
$
   
$
18,830
 
Short exchange-traded options
   
4,860
     
     
     
4,860
 
Other
   
1,681
     
     
     
1,681
 
Derivatives
   
32
     
6,659
     
     
6,691
 
Total liabilities measured at fair value
 
$
25,403
 
 
$
6,659
 
 
$
   
$
32,062
 


   
December 31, 2011
 
   
Level 1
  
Level 2
  
Level 3
  
Total
 
   
(in thousands)
 
              
Money markets
 $340,548  $  $  $340,548 
U.S. Treasury bills
     1,277,944      1,277,944 
U.K. Treasury bills
     119      119 
Equity securities
                
Growth
  107,802   189      107,991 
Value
  60,096   9      60,105 
Blend
  118,208         118,208 
Other(1)
  45,583         45,583 
Fixed Income securities
                
Taxable(2)
  110,062   14,488      124,550 
Tax-exempt(3)
  15,366   743      16,109 
Other
  17         17 
Derivatives
  127   3,494      3,621 
Long exchange-traded options
  14,322         14,322 
Private equity
  11,592      64,466   76,058 
Total assets measured at fair value
 $823,723  $1,296,986  $64,466  $2,185,175 
                  
Securities sold not yet purchased
                
Short equities – corporate
 $34,469  $  $  $34,469 
Short exchange-traded options
  3,567         3,567 
Other
  1,271         1,271 
Derivatives
  2,054   5,205      7,259 
Total liabilities measured at fair value
 $41,361  $5,205  $  $46,566 
________________
(1)
Primarily long positions in corporate equities traded through our options desk.
(2)
Primarily corporate and government securities.
(3)
Primarily municipal bonds.
Fair value measurement Level 3 reconciliation
The following table summarizes the change in carrying value associated with Level 3 financial instruments carried at fair value:

   
Three Months Ended
September 30,
  
Nine Months Ended
September 30,
 
   
2012
  
2011
  
2012
  
2011
 
   
(in thousands)
 
              
Balance as of beginning of period
 $57,908  $59,524  $64,466  $59,414 
                  
Transfer (out) in, net
        (13,548)  (3,588)
Purchases
  3,467   577   7,300   7,993 
Sales
     (1)  (1,823)  (214)
Realized gains (losses), net
  (8,379)  (246)  (7,524)  (3,106)
Unrealized gains (losses), net
  8,666   (1,371)  12,791   (2,016)
Balance as of end of period
 $61,662  $58,483  $61,662  $58,483 
Information about Level 3 fair value measurements
The following table provides quantitative information about Level 3 fair value measurements:

   
Fair Value
as of
September 30,
2012
 
Valuation Technique
 
Unobservable
Input
 
Range
 
   
(in thousands)
         
Private Equity:
           
             
Technology, Media and Telecommunications
 $23,256 
Market comparable companies
 
Revenue multiple
  2.5 – 6  
         
Discount rate
  18%
         
Discount years
  1 – 2  
               
Healthcare and Cleantech
 $14,871 
Market comparable companies
 
Revenue multiple
  0.7 – 45.9 
         
R&D multiple
  1.3 – 37.4  
         
Discount for lack of marketability and risk factors
  50-60%